These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. My views on intrasmuscular pain-killing. Sheriff B. Nurs Times; ; 79(17):53. PubMed ID: 6551854 [No Abstract] [Full Text] [Related]
5. Decreased local toxicity with subcutaneous diamorphine (heroin): a preliminary report. Bruera E, Macmillan K, Selmser P, MacDonald NR. Pain; 1990 Oct; 43(1):91-94. PubMed ID: 1703651 [Abstract] [Full Text] [Related]
6. [Value of intraventricular morphine analgesia in intractable neoplasm pain. Apropos of 8 cases with self-administration in 4]. Roquefeuil B, Benezech J, Batier C, Blanchet P, Gros C, Mathieu-Daude JC. Neurochirurgie; 1983 Oct; 29(2):135-41. PubMed ID: 6888632 [Abstract] [Full Text] [Related]
7. Changes in practice in the use of subcutaneous diamorphine via syringe driver. McGettrick S, Rodgers J. Health Bull (Edinb); 1996 Sep; 54(5):390-4. PubMed ID: 8936806 [Abstract] [Full Text] [Related]
8. Intraventricular diamorphine via an Ommaya shunt for intractable cancer pain. Reeve WG, Todd JG. Br J Anaesth; 1990 Oct; 65(4):544-7. PubMed ID: 2248824 [Abstract] [Full Text] [Related]
18. [Treatment of cancer pain by continuous subcutaneous infusion of buprenorphine]. Umeda S, Noda J, Arai T, Omatsu Y, Moriyama S, Harima A. Gan No Rinsho; 1986 May 20; 32(5):497-500. PubMed ID: 3723808 [Abstract] [Full Text] [Related]